Collaboration is a huge topic in healthcare today. The industry is evolving extremely fast, and while that brings with it plenty of opportunity, it also creates new challenges.
Oliver Stohlmann’s Corporate Survival Hacks series draws on experiences of working in local, regional, and global life sciences communications to offer some little tips for enjoying a big b
Zealand Pharma has suffered another setback in its bid to bring glucagon receptor agonist dasiglucagon for ultra-rare disease congenital hyperinsulinism (CHI) to the US market.